16 marzo 2015
The commercial track record with transcatheter mitral valve repair, approved for patients at high risk for surgery, compares favorably with pre-approval reports, according to findings from a US registry.
http://feeds.sciencedaily.com/~r/sciencedaily/~3/GW4M_px80Z8/150316102106.htm
